Genedrive
LightNews LightNews
banner
genedrive.bsky.social
Genedrive
@genedrive.bsky.social
21 followers 23 following 35 posts
Transforming patient outcomes through pharmacogenetics

www.genedrive.com
Posts Replies Media Videos
genedrive.bsky.social
Genedrive® MT-RNR1 ID Kit is a rapid genetic test designed to be used in time critical situations, prior to antibiotic treatment prescription.

Its provides the result of an individual’s MT-RNR1 gene variant status to inform clinicians ahead of antibiotic treatment decisions, in 26 minutes.
August 12, 2025 at 4:21 PM
genedrive.bsky.social
Join the genedrive team for this key event for East Midlands NHS and healthcare organisations.

📅 Sep 18th at the Nottingham Belfry Hotel
Bringing together colleagues to explore opportunities for innovation to help transform care in your areas.

Register healthinnovation-em.org.uk/component/rs...
August 7, 2025 at 10:22 AM
genedrive.bsky.social
Keep an eye on the Genedrive website this week...

#GDR
July 7, 2025 at 3:24 PM
genedrive.bsky.social
Keep an eye on the Genedrive website this week...

#GDR
July 7, 2025 at 3:23 PM
genedrive.bsky.social
We had a fantastic day at the ONE BioHub Innovate MedTech North Conference yesterday!

Thank you to the event organisers and speakers for putting together an excellent event.

#GDR #innovation #diagnostics #medtech #genetics #genomics #POCT #pharmacogenetics #pharmacogenomics
July 4, 2025 at 2:23 PM
genedrive.bsky.social
TOMORROW you can find @Gino Miele and @Stacey Gardiner at the ONE BioHub Innovate MedTech North Conference in Aberdeen!

Contact enquiries@genedrive.com to book a meeting.

#GDR #POCT #pointofcare #pharmacogenomics #pharmacogenetics #diagnostics #genetics
July 2, 2025 at 10:19 AM
genedrive.bsky.social
Testing for CYP2C19 metaboliser status is important in ensuring patients get the right treatment at the right time.

Learn more: www.genedrive.com/assays/cyp2c...

#GDR #POCT #Cardiology #Genetics #Pharmacogenetics #Pharmacogenomics #Stroke #Diagnostics #NHS #CYP2C19
June 30, 2025 at 2:00 PM
genedrive.bsky.social
This week, Genedrive CEO Dr. Gino Miele talked about the company’s progress in rapid pharmacogenetic testing for emergency care at the Proactive One2One Investor Forum.

📺 Watch now: www.youtube.com/watch?v=MrfH...

#GDR #genetics #pharmacogenetics #pharmacogenomics #diagnostics #healthcare
Genedrive CEO on rapid genetic testing rollout - One2One Investor Forum
YouTube video by Proactive Investors
www.youtube.com
June 27, 2025 at 12:55 PM
genedrive.bsky.social
Not all antiplatelets work equally for everyone…

The Genedrive CYP2C19 ID Kit has recently been CE marked, and guides treatment by providing rapid, actionable genetic results.

Learn more: www.genedrive.com/assays/cyp2c...

#GDR #POCT #patientsafety #pointofcare #pharmacogenomics #pharmacogenetics
June 16, 2025 at 8:09 AM
genedrive.bsky.social
CPIC guidelines recommend CYP2C19 genotyping for patients undergoing PCI.

The Genedrive CYP2C19 ID Kit provides rapid, actionable genetic results to aid clinicians in these vital decisions.

Read more: www.genedrive.com/assays/cyp2c...

#GDR #pharmacogenomics #diagnostics #genetics #genomics
June 13, 2025 at 8:09 AM
genedrive.bsky.social
It’s just 1 WEEK until the #UKPGx2025 12th Annual Meeting in London!

Learn more: my.bps.ac.uk/events/detai...

#GDR #Pharmacogenetics #Genetics #Pharmacogenomics #POCT #pointofcare #diagnostics #genomics
June 11, 2025 at 8:09 AM
genedrive.bsky.social
Meta-analysis found that patients with CYP2C19 variants on clopidogrel had significantly higher rates of ischaemic events after PCI.

Using the Genedrive CYP2C19 ID Kit before prescription could help reduce these risks.

Read more: www.genedrive.com/assays/cyp2c...

#GDR #pharmacogenomics #genetics
June 9, 2025 at 8:09 AM
genedrive.bsky.social
Pharmacogenetics can transform how we manage ACS and PCI.

The now CE marked, Genedrive CYP2C19 ID Kit provides genetic results rapidly to inform clinicians and guide their treatment decisions.

Learn more: www.genedrive.com/assays/cyp2c...

#GDR #POCT #Stroke #patientsafety #pharmacogenomics
June 6, 2025 at 11:11 AM
genedrive.bsky.social
In 2 WEEKS, we’ll be exhibiting at the Welsh Stroke Conference!

At the All Nations Conference Centre in Cardiff

Learn more: welshstrokeconference.co.uk

#GDR #POCT #Stroke #patientsafety #pointofcare #pharmacogenomics #pharmacogenetics #StrokeAwareness #Wales
June 4, 2025 at 11:54 AM
genedrive.bsky.social
We are delighted that both of our pharmacogenetic tests are now available for order via the NHS supply chain!

Contact enquiries@genedrive.com for more information

#GDR #pharmacogenomics #pharmacogenetics #diagnostics #POCT #genetics #pointofcare #NHS
June 2, 2025 at 8:09 AM
genedrive.bsky.social
We are delighted that the Genedrive CYP2C19 ID Kit has received CE-certification under the European In Vitro Diagnostics Regulation!

Read the RNS: www.genedrive.com/news/index.php

#GDR #POCT #pharmacogenomics #pharmacogenetics #diagnostics #pointofcare #stroke #cardiology #genetics #DEVOTE
May 30, 2025 at 10:12 AM
genedrive.bsky.social
Every stroke can have a devastating impact on a family.

In around a third of people, clopidogrel, one of the main antiplatelet drugs, is not working effectively.

Learn how genetic testing can help: www.genedrive.com/assays/cyp2c...
May 30, 2025 at 8:09 AM
genedrive.bsky.social
In ONE month we will be sponsoring the UKPGx 12th Annual Meeting in London!

Join us for an exciting day of talks around developments in the field of pharmacogenetics.

#GDR #pharmacogenomics #POCT #diagnostics #UKPGx2025
May 28, 2025 at 8:09 AM
genedrive.bsky.social
Implementing the Genedrive® CYP2C19 ID Kit to guide therapy could prevent recurrent strokes and reduce healthcare costs.

Learn more on our website: www.genedrive.com/assays/cyp2c...

#StrokeAwarenessMonth #PrecisionMedicine #StrokePrevention #Pharmacogenomics #PublicHealth #GDR
May 26, 2025 at 8:09 AM
genedrive.bsky.social
Clopidogrel is key in stroke therapy — but it doesn’t work for everyone.

Genotype-guided therapy, using the Genedrive® CYP2C19 ID Kit, helps identify clopidogrel-resistant patients.

Learn how: www.genedrive.com/assays/cyp2c...

#StrokeAwarenessMonth #PrecisionMedicine #Pharmacogenomics #GDR
May 23, 2025 at 8:09 AM
genedrive.bsky.social
Join us on Stand D8 for day 1 of ESOC 2025 in Helsinki!

Discover how our innovative genetic test can guide antiplatelet therapy following a stroke.

Learn more: eso-stroke.org/esoc2025/

#GDR #POCT #Stroke #ESOC2025 #Pharmacogenomics
May 21, 2025 at 8:47 AM
genedrive.bsky.social
THIS WEEK we'll be at the 11th European Stroke Organisation Conference (ESOC 2025). Visit our stand to explore genetic testing to guide antiplatelet therapy via CYP2C19 metaboliser status. Learn more: eso-stroke.org/esoc2025/
#GDR #POCT #Stroke #pharmacogenomics #StrokeAwareness #ESOC2025
May 19, 2025 at 8:09 AM
genedrive.bsky.social
May is Stroke Awareness Month. 1 in 4 will experience a stroke, the second leading cause of death and third for combined death and disability worldwide.

Visit our website to see how we’re tackling this challenge: www.Genedrive.com/assays/cyp2c19

#GDR #StrokeAwarenessMonth #StrokePrevention
May 16, 2025 at 8:09 AM
genedrive.bsky.social
Genedrive will be showcasing their innovations at the POCT Innovators Clinical Innovation EXPO tomorrow!

Reach out to enquiries@genedrive.com to arrange a meeting.

#GDR #POCT #pointofcare #pharmacogenomics #pharmacogenetics #diagnostics #genetics #innovation
May 14, 2025 at 8:09 AM
genedrive.bsky.social
The Genedrive CYP2C19 ID Kit is being used in a trial led by @mftnhs.bsky.social in collaboration with the Genotype Guided Primary Coronary Intervention programme and the BHF Centre of Excellence!

Read more: www.genedriveplc.com/press-releas...

#GDR #cardiology #genetics #clopidogrel
May 13, 2025 at 8:45 AM